Cue Biopharma, Inc. (CUE) insider trading
Over the last 12 months, 1 insider bought $99.7K and 3 insiders sold $2.43M of Cue Biopharma, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Oct 12, 2026: Ray Sumita sold 1,844 shares ($51.7K)
- Oct 12, 2026: Lin Shao-Lee sold 11,087 shares ($305K)
- Oct 12, 2026: Meluzio Michael Vincent sold 1,144 shares ($32.1K)
- Aug 13, 2026: Meluzio Michael Vincent sold 5,628 shares ($169K)
- Aug 13, 2026: Ray Sumita sold 8,829 shares ($266K)
- Aug 13, 2026: Lin Shao-Lee sold 58,258 shares ($1.61M)
- Dec 30, 2025: Sarraf Pasha bought 323,857 shares ($99.7K)
- Dec 16, 2024: Passeri Daniel R bought 30,000 shares ($30.9K)